PRNewsWire
01 Jan 2026, 15:00 UTC · 43w ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
Impact · against what's priced in
XOMA and RZLT face significant negative catalysts following the failure of the Phase 3 sunRIZE study for ersodetug. While XOMA's stock has already dropped 22.76% following the trial results, the subsequent launch of a securities fraud investigation by Pomerantz LLP introduces new legal risk.
- RZLT−0.80
No priced-in read yet





